Bristol-Myers Squibb CompanyBMYNYSE
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank15
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P15
Within normal range
vs 3Y Ago
-2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -50.66% |
| Q3 2025 | 68.02% |
| Q2 2025 | -46.66% |
| Q1 2025 | 3311.11% |
| Q4 2024 | -94.05% |
| Q3 2024 | -27.92% |
| Q2 2024 | 114.10% |
| Q1 2024 | -775.99% |
| Q4 2023 | -8.61% |
| Q3 2023 | -6.99% |
| Q2 2023 | -8.36% |
| Q1 2023 | 11.87% |
| Q4 2022 | 25.90% |
| Q3 2022 | 13.02% |
| Q2 2022 | 11.19% |
| Q1 2022 | -46.12% |
| Q4 2021 | 53.43% |
| Q3 2021 | 46.54% |
| Q2 2021 | -47.80% |
| Q1 2021 | 120.16% |
| Q4 2020 | -635.63% |
| Q3 2020 | 2302.35% |
| Q2 2020 | 89.03% |
| Q1 2020 | 26.61% |
| Q4 2019 | -178.05% |
| Q3 2019 | -5.52% |
| Q2 2019 | -16.26% |
| Q1 2019 | 47.41% |
| Q4 2018 | -38.98% |
| Q3 2018 | 409.65% |
| Q2 2018 | -74.90% |
| Q1 2018 | 163.83% |
| Q4 2017 | -375.50% |
| Q3 2017 | -7.75% |
| Q2 2017 | -41.80% |
| Q1 2017 | 76.06% |
| Q4 2016 | -25.62% |
| Q3 2016 | 3.09% |
| Q2 2016 | -2.43% |
| Q1 2016 | 706.60% |